Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CTP Newsroom

CTP Newsroom

                        Feature Stories Home
          Tobacco Products
          CTP Newsroom
          FDA, DOJ Seek Permanent Injunction Against E-Cigarette ManufacturerCTP Newsroom FDA, DOJ Seek Permanent Injunction Against E-Cigarette Manufacturer
  
  					Manufacturer failed to take corrective action after being warned it was violating the law
	
    Share
    Post
    Linkedin

    Email
    PrintOn December 4, 2023, the U.S. Department of Justice (DOJ), on behalf of FDA, filed a complaint for a permanent injunction against Jessica M. Fitzgerald and Michelle L. Allen doing business as Vape Junkie Ejuice (Vape Junkie Ejuice) for manufacturing, selling, and distributing unauthorized e-cigarette products. This case represents the seventh time FDA has initiated injunction proceedings to enforce the Federal Food, Drug, and Cosmetic Act’s (FD&C Act) premarket review requirements for new tobacco products.

Vape Junkie Ejuice was previously warned by FDA that they were in violation of the FD&C Act’s premarket review requirements for new tobacco products by manufacturing, selling, and distributing new tobacco products without first obtaining marketing authorization from FDA. FDA’s warning noted that continued violations could lead to further action, including injunction. However, Vape Junkie Ejuice continued to manufacture, sell, and distribute unauthorized e-cigarette products to consumers.

“FDA has been abundantly clear that we will not stand by as bad actors choose to blatantly disregard the law, especially after being duly warned,” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products (CTP). “This manufacturer continued to break the law, and that behavior has consequences.”

DOJ institutes judicial enforcement actions under the FD&C Act in court. Accordingly, DOJ filed the injunction complaint on behalf of FDA against Vape Junkie Ejuice in the Middle District of Florida, the manufacturer’s respective U.S. District Court. The injunction sought would require Vape Junkie Ejuice to stop manufacturing, selling, and distributing their e-liquids. The injunction would also require the manufacturer to obtain marketing authorization from FDA before marketing such products, as required by law.

In these types of cases, defendants can agree to settle and agree not to manufacture, sell, or distribute any new tobacco products until certain requirements are met. These requirements include that the tobacco products receive FDA marketing authorization, that the agency inspect the defendants’ facilities to determine compliance with the law, and that FDA notify defendants in writing that they appear to be in compliance with the law. For those defendants who do not agree to settle, the U.S. government can request the relevant courts to enter injunctions preventing those defendants from directly or indirectly manufacturing, selling, or distributing any unauthorized tobacco products.

“Today’s injunction action should be a clear reminder to all manufacturers: If you continue to sell illegal products, we are equipped to use the full force of the law,” said Ann Simoneau, director of CTP’s Office of Compliance and Enforcement. “FDA is committed to working with federal partners, including the Department of Justice, to enforce the law.”

Today’s action is part of FDA’s comprehensive approach to enforcing the law. Within the past year, FDA has taken actions against manufacturers, distributors, importers, and retailers of illegal e-cigarette products. As of November 2023, FDA has issued approximately 640 warning letters to firms for manufacturing and/or distributing illegal e-cigarette products and devices, issued more than 400 warning letters to retailers for the sale of unauthorized e-cigarettes, filed civil money penalty complaints against 36 e-cigarette manufacturers and 42 retailers for manufacture and/or sale of unauthorized products.

                                                                                  Content current as of:
      12/04/2023
              
              
Regulated Product(s)
		 TobaccoCTP Newsroom

          
                        Feature Stories
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop